What EVIQ does

eviQ is a free, web-based clinical decision support platform that provides evidence-based, consensus-driven cancer treatment protocols and information to Australian healthcare professionals at the point of care. It is owned and operated by the Cancer Institute NSW, a New South Wales state government cancer control agency headquartered in St Leonards, Sydney, and is funded through the NSW government health budget. The platform is open-access (clinical content is available without registration) and serves clinicians across medical oncology, radiation oncology, haematology, cellular therapies, and cancer genetics. There is no commercial pricing, no venture capital or private equity investment, and no IPO path; the entity operates strictly as a non-profit government health initiative.

The core product is a comprehensive protocol database organised by clinical discipline and tumour site, including site-specific medical oncology regimens (breast, colorectal, gynaecological, head and neck, neurological, respiratory, sarcoma, skin, upper gastrointestinal, urogenital, rare cancers, tumour-agnostic), radiation oncology protocols, leukaemia and lymphoma regimens, multiple myeloma, blood and marrow transplant protocols, CAR T-cell therapies, and adult and paediatric cancer genetics protocols. This core is supplemented by clinical resources (eviQ calculators, assessment tools, anti-cancer drug administration guidelines, central venous access device guidance, extravasation management, side effect and toxicity management, a telephone triage toolkit, and a dosing-in-kidney-dysfunction guideline), patient and carer information sheets in ten languages, an essential medicines list, and an essential medicines list for Aboriginal health workers.

Two named sub-brands extend the platform: eviQ Education, which delivers free web-based eLearning courses such as the Antineoplastic Drug Administration Course (ADAC) and the Radiation Oncology Nursing Course that allow clinicians to earn CPD hours, and eviQ Calculators, a set of clinical decision tools for treatment planning. The platform's geographic scope is principally Australia (with explicit caveats advising international users to verify local applicability), and its content is endorsed by medical professionals and updated on an ongoing basis, with documented milestones dating to at least 2009 and active updates continuing into 2025. The go-to-market motion is non-commercial: distribution relies on institutional relationships within the Australian public health system, cross-referrals from sister Cancer Institute NSW sites (BreastScreen NSW, Cervical Screening NSW, Canrefer, iCanQuit), and word-of-mouth adoption among oncology clinicians.

Name

EVIQ

Legal name

eviQ - Cancer Treatments Online

Website

https://eviq.org.au

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

eviQ is a free, web-based clinical decision support platform operated by the Cancer Institute NSW, providing evidence-based cancer treatment protocols, clinical calculators, and eLearning resources to Australian healthcare professionals at the point of care.

Ownership category

akta.pro rank

Product category

Clinical Decision Support

NAICS

Other Scientific and Technical Consulting Services (541690)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Enterprise Content Management (ECM) Suites (HDAEAGAB)

Keywords

• Cancer treatment protocols
• Clinical decision support
• Oncology education
• Evidence-based medicine
• Healthcare professional resources

Headquarters

HQ city

Sydney

HQ country

Australia

HQ region

Oceania

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Others

Core offering

EVIQ provides a free, web-based library of evidence-based, consensus-driven cancer treatment protocols covering medical oncology, radiation oncology, haematology, cellular therapies (including CAR T-cell and BMT), and cancer genetics, intended for use by Australian health professionals at the point of care. It supplements these protocols with clinical calculators, assessment tools, side-effect management guidelines, and patient information sheets in multiple languages. An associated eviQ Education platform delivers CPD-eligible eLearning courses (e.g., ADAC, Radiation Oncology Nursing).

Product overview

eviQ is a unified, web-based clinical decision support platform operated by the Cancer Institute NSW, providing free access to evidence-based, consensus-driven cancer treatment protocols and information for Australian health professionals at the point of care. The platform consists of a core protocol database covering medical oncology, radiation oncology, haematology, cellular therapies, and cancer genetics, supplemented by clinical resource tools (calculators, assessment guides, side effect management algorithms), patient and carer information materials in multiple languages, and an eLearning platform (eviQ Education) for professional development. The protocol database is the central product, while clinical resources, patient information, and education are supporting modules that enhance the utility of the core protocol system.

Differentiator

Problem solved

Functional benefit

Brands

• eviQ Education: Free web-based eLearning resources for cancer health professionals to earn CPD hours.
• eviQ Calculators

Products and services

• eviQ Cancer Treatment Protocols A free, web-based library of evidence-based, consensus-driven cancer treatment protocols and information developed for the Australian context, supporting health professionals in the delivery of cancer treatments at the point of care.
• eviQ Education Free web-based eLearning platform providing courses such as the Antineoplastic Drug Administration Course (ADAC) and the Radiation Oncology Nursing Course, allowing cancer health professionals to earn CPD hours.
• Clinical Resources A collection of clinical tools and guidelines supporting cancer treatment delivery, including assessment tools, administration guidelines, central venous access device (CVAD) resources, extravasation management, oncological emergency guidance, and side effect and toxicity management resources for oncology clinicians.
• eviQ Calculators Clinical calculators designed to support cancer treatment planning and assessment, used by oncology clinicians at the point of care.
• Patients and Carers Information Patient-facing information covering anticancer drug and radiation therapy treatments, cancer genetics, side effect management, and general care topics, with multilingual sheets available in Arabic, Chinese (Simplified and Traditional), French, Greek, Italian, Korean, Spanish, Vietnamese, Macedonian, and Thai.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• ApscocoreStrategic or Co-development Partner · 23 October 2025EVIQ partnered with Apsco to expand the Saudi EV charging network. This partnership is part of Saudi Arabia's broader sustainability goals under Vision 2030 initiatives.
• PetromincoreStrategic or Co-development Partner · 8 August 2025EVIQ has established a partnership with Petromin for EV charging infrastructure development. This partnership is noted as a key development in the Saudi Arabia fuel station market as the industry shifts toward alternative fuels including EV charging stations.

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• UpToDate (Wolters Kluwer): UpToDate is a subscription-based clinical decision support resource covering oncology and all major medical specialties. It competes with eviQ for clinician attention at the point of care but is a commercial product with broader scope and continuous AI-enhanced updates.
• National Cancer Institute (NCI): The NCI, a US government agency, provides comprehensive cancer treatment information, physician data query (PDQ) protocols, and patient education materials. It is comparable to eviQ as a government-backed cancer information resource, though it operates at significantly larger scale and scope.
• American Society of Clinical Oncology (ASCO): ASCO develops clinical practice guidelines, hosts oncology education, and publishes research in oncology. It is comparable to eviQ as a professional society providing treatment guidance, though ASCO operates commercially and internationally with a much larger membership base.
• BMJ Best Practice: BMJ Best Practice provides evidence-based clinical decision support including oncology content, structured similarly to eviQ's protocol-plus-calculator model. It is a commercial subscription product used internationally and competes for institutional adoption in Australian hospitals.

Regional players

• National Institute for Health and Care Excellence (NICE): NICE develops evidence-based clinical guidelines and treatment recommendations for the UK NHS, including cancer treatment pathways. It is comparable to eviQ as a government-backed clinical guidance developer, though NICE operates in a different national context.
• Cancer Council Australia: Cancer Council Australia develops Australian cancer clinical guidelines and patient information, directly comparable to eviQ's domestic role. Both are Australian-focused cancer information providers, though Cancer Council emphasizes prevention and screening while eviQ focuses on treatment protocols.

Direct peers

• National Comprehensive Cancer Network (NCCN): NCCN develops evidence-based cancer treatment guidelines used by clinicians at the point of care, directly comparable to eviQ's protocol database. Both serve as authoritative consensus-driven oncology reference resources, with NCCN operating primarily in the US.
• European Society for Medical Oncology (ESMO): ESMO publishes clinical practice guidelines for cancer treatment across medical oncology, comparable in scope and evidence-based methodology to eviQ's Medical Oncology and Haematology protocols. Both serve as consensus-driven international oncology reference standards.

Others

• eviQ Education (sub-brand): eviQ Education is a free web-based eLearning platform for cancer health professionals offering CPD-eligible courses such as ADAC. It is comparable to commercial oncology nursing education providers and represents a distinct but related capability within the eviQ ecosystem.

Emerging players

• DynaMed (EBSCO): DynaMed is a subscription-based clinical decision support tool with oncology content updated daily by physician editors, competing with eviQ for point-of-care usage. It is comparable as a structured clinical reference with decision support tools, though commercially funded.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EVIQ